TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18087204

Group type: EXPERIMENTAL
Intervention: Maintenance antidepressant (AD) medication
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Intermittent use of antidepressants
Number of subjects: 172

Group type: COMPARATOR
Intervention: Stopping antidepressants with additional preventive cognitive therapy (CT)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Non-AD-using patients treated with usual care
Number of subjects: 172
Study: 16877900

Group type: EXPERIMENTAL
Intervention: Duloxetine (40-120 mg/day)
Number of subjects: 2577

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2577

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 2577
Study: 12527617

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (group V)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Manual ventilation (group M)
Number of subjects: 16
Study: 10650299

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9345375

Group type: EXPERIMENTAL
Intervention: Linomide (p.o.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1751434

Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone orally 36 h before operation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1 mg gemeprost vaginal pessary 3‐4 h preoperatively
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (identical oral placebo)
Number of subjects: 90
Study: 6297363

Group type: EXPERIMENTAL
Intervention: Synthetic human beta‐EP by constant rate IV infusion
Number of subjects: 18
Study: 31249403

Group type: EXPERIMENTAL
Intervention: His bundle pacing (HBP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: RV apical pacing
Number of subjects: 0
Study: 30792049

Group type: EXPERIMENTAL
Intervention: Antecolic reconstruction
Number of subjects: 30

Group type: COMPARATOR
Intervention: Retrocolic reconstruction
Number of subjects: 30
Study: 27687308

Group type: EXPERIMENTAL
Intervention: Early palliative care team referral
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard oncology care with palliative care only as needed
Number of subjects: 182
Study: 25907583

Group type: EXPERIMENTAL
Intervention: Informed consent procedure (participant information sheet, informed consent form, and AUDIT questionnaire)
Number of subjects: 380

Group type: COMPARATOR
Intervention: AUDIT questionnaire only (comparator group)
Number of subjects: 380
Study: 23128033

Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment at 5.1 J/cm² (L(1))
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment at 2.0 J/cm² (L(2))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no laser treatment)
Number of subjects: 12
Study: 21785107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2021
Study: 19796823

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 17102001

Group type: EXPERIMENTAL
Intervention: Latanoprost-timolol fixed combination dosed in the evening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Timolol alone dosed twice daily
Number of subjects: 0
Study: 14724871

Group type: EXPERIMENTAL
Intervention: Cephalexin/penicillin combination
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 11769363

Group type: EXPERIMENTAL
Intervention: Family psychosocial intervention at diagnosis
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (hospital ward treatment)
Number of subjects: 36
Study: 9397322

Group type: EXPERIMENTAL
Intervention: Strength training only (S)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Endurance training only (E)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combined strength and endurance training (SE)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 45
Study: 7555508

Group type: EXPERIMENTAL
Intervention: Acarbose 100 mg three times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acarbose 200 mg three times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acarbose 300 mg three times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acarbose (all doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2124925

Group type: EXPERIMENTAL
Intervention: High-fat diet (F)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Carbohydrate diet (C)
Number of subjects: 8
Study: 446319

Group type: EXPERIMENTAL
Intervention: Cimetidine 1.6 g/d
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 30221400

Group type: EXPERIMENTAL
Intervention: Probe-based confocal laser endomicroscopy (pCLE)
Number of subjects: 91

Group type: COMPARATOR
Intervention: White light endoscopy (WLE)
Number of subjects: 91
Study: 28241356

Group type: EXPERIMENTAL
Intervention: Testosterone gel for 1 year
Number of subjects: 493

Group type: COMPARATOR
Intervention: Placebo gel for 1 year
Number of subjects: 493
Study: 25878304

Group type: EXPERIMENTAL
Intervention: Open reduction and plate fixation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intramedullary nailing
Number of subjects: 120
Study: 24281841

Group type: EXPERIMENTAL
Intervention: Bovine colostrum (60 g/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Whey protein (38 g protein)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both colostrum and whey protein
Number of subjects: 40
Study: 22157845

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125% (Group B)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125% plus epinephrine 1:200 000 (Group BE)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Epinephrine 1:200 000 (Group E)
Number of subjects: 105
Study: 20231228

Group type: EXPERIMENTAL
Intervention: Remifentanil (3 microg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fentanyl (2 microg/kg) and succinylcholine (2 mg/kg)
Number of subjects: 30
Study: 17664059

Group type: EXPERIMENTAL
Intervention: Infant formula with 0.6 g/100 mL of galacto-oligosaccharides (GOS) and long-chain fructo-oligosaccharides (lcFOS) in a ratio of 9/1
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control infant formula
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Infant formula with GOS/lcFOS
Number of subjects: 215
Study: 16297753

Group type: EXPERIMENTAL
Intervention: 1.5 mg/mL levobupivacaine (bolus 3.3 mL, lockout 20 minutes, n = 26)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 5 mg/mL levobupivacaine (bolus 1 mL, lockout 20 minutes, n = 23)
Number of subjects: 49
Study: 12475852

Group type: EXPERIMENTAL
Intervention: Diuretics and colloids
Number of subjects: 37

Group type: COMPARATOR
Intervention: Dual placebo
Number of subjects: 37
Study: 9259653

Group type: EXPERIMENTAL
Intervention: Cystography
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Family history screening
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: DMSA radioisotope scan
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Renal ultrasound
Number of subjects: 211
Study: 8332149

Group type: EXPERIMENTAL
Intervention: Holter monitoring
Number of subjects: 486

Group type: COMPARATOR
Intervention: Electrophysiologic study
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Previous responders to antiarrhythmic drugs
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Overall drug therapy success
Number of subjects: 486
Study: 3553008

Group type: EXPERIMENTAL
Intervention: 7‐S‐immunoglobulins
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (not treated with immunoglobulins)
Number of subjects: 44
Study: 29607761

Group type: EXPERIMENTAL
Intervention: Hip arthroscopic procedures
Number of subjects: 240

Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 240
Study: 27156803

Group type: EXPERIMENTAL
Intervention: Medical needling combined with non-cultured autologous skin cell suspension (NCASCS)
Number of subjects: 20
Study: 25444575

Group type: EXPERIMENTAL
Intervention: Resistance training (high intensity progressive resistance training)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cognitive training
Number of subjects: 100
Study: 22956551

Group type: EXPERIMENTAL
Intervention: 5 mg oral prednisolone daily for 4 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 20633522

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 63
Study: 18583886

Group type: EXPERIMENTAL
Intervention: Mild cognitive impairment (MCI) patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Elderly normal controls
Number of subjects: 22
Study: 16211697

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (CE) and medroxyprogesterone acetate (MPA) at a dose of 0.625/2.5 mg daily for 24 weeks
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (CE) and medroxyprogesterone acetate (MPA) at a dose of 0.45/1.5 mg daily for 24 weeks
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (CE) and medroxyprogesterone acetate (MPA) at a dose of 0.3/1.5 mg daily for 24 weeks
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: Vaginal responsiveness evaluated by the vaginal maturation index (VMI) at baseline and at week 24
Number of subjects: 1028
Study: 11908554

Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg
Number of subjects: 894

Group type: EXPERIMENTAL
Intervention: Meloxicam 15 mg
Number of subjects: 894

Group type: EXPERIMENTAL
Intervention: Meloxicam 22.5 mg
Number of subjects: 894

Group type: COMPARATOR
Intervention: Diclofenac 150 mg
Number of subjects: 894

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 894

Group type: EXPERIMENTAL
Intervention: All doses of meloxicam and diclofenac
Number of subjects: 894
Study: 10579069

Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization (TMR)
Number of subjects: 0
Study: 8776076

Group type: EXPERIMENTAL
Intervention: Individualized exercise conditioning program for 15 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Oral drug therapy
Number of subjects: 39
Study: 1760998

Group type: EXPERIMENTAL
Intervention: Low fat diet (25% of energy) with low P/S ratio (less than 0.4)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: High fat diet (35% of energy) with high P/S ratio (greater than 1.0)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Low fat diet (25% of energy) with high P/S ratio (greater than 1.0)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: High fat diet (35% of energy) with low P/S ratio (less than 0.4)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (6 g daily for four weeks)
Number of subjects: 4
Study: 6122098

Group type: EXPERIMENTAL
Intervention: GL enzyme
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 31640992

Group type: EXPERIMENTAL
Intervention: Self-management programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-management programme plus a verum thumb splint
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-management programme plus a placebo thumb splint
Number of subjects: 0
Study: 30089430

Group type: EXPERIMENTAL
Intervention: 10,000 therapeutic units (TU) of Dermatophagoides pteronyssinus allergoid preparation
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: 18,000 therapeutic units (TU) of Dermatophagoides pteronyssinus allergoid preparation
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 27100435

Group type: EXPERIMENTAL
Intervention: Rapid infancy weight gain (weight-for-age Z score gain >0.67 between birth and 1.5 years)
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: Rapid infancy weight gain
Number of subjects: 581
Study: 24663007

Group type: EXPERIMENTAL
Intervention: Twin Block (TB) appliance therapy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Herbst appliance therapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both TB and Herbst appliances
Number of subjects: 39
Study: 22324448

Group type: EXPERIMENTAL
Intervention: Synbiotic formulation containing Lactobacillus paracasei B21060, arabinogalactan and xilooligosaccharides
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Synbiotic formulation
Number of subjects: 107
Study: 19224955

Group type: EXPERIMENTAL
Intervention: Q measurement system implemented in hospitals
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Q measurement system
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Operational costs of implementing Q
Number of subjects: 30
Study: 17608790

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 35048

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 35048

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 35048

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 35048

Group type: EXPERIMENTAL
Intervention: AGT-6 genotype 'G/G' in men
Number of subjects: 35048

Group type: EXPERIMENTAL
Intervention: AGT-6 genotype 'G/G' in women
Number of subjects: 35048

Group type: EXPERIMENTAL
Intervention: ACE-I/D genotype
Number of subjects: 35048
Study: 15140460

Group type: EXPERIMENTAL
Intervention: decision analytic decision aid (DA)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: computerised decision aid
Number of subjects: 15
Study: 11148745

Group type: EXPERIMENTAL
Intervention: Holmium laser prostatectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interstitial laser prostatectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neodymium:yttrium‐aluminum‐garnet laser
Number of subjects: 0
Study: 9672822

Group type: EXPERIMENTAL
Intervention: Coached malingerers
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Naive malingerers
Number of subjects: 92

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 92
Study: 8076564

Group type: EXPERIMENTAL
Intervention: 1:10,000 epinephrine in water (Group I)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Distilled water (Group II)
Number of subjects: 52
Study: 2644753

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with bupivacaine 50 mg via an epidural catheter, maintained by continuous infusion for 24 hours postoperatively.
Number of subjects: 16

Group type: COMPARATOR
Intervention: General anesthesia only (control group).
Number of subjects: 16
Study: 186225

Group type: EXPERIMENTAL
Intervention: Oral ingestion of orthophosphate (Pi)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Renal arterial infusion of orthophosphate (Pi) in dogs
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Simultaneous intravenous infusion of PPi in dogs
Number of subjects: 10

Group type: COMPARATOR
Intervention: Infusion of PPi in dogs
Number of subjects: 10
Study: 29093253

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention for one year
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine health education (Control)
Number of subjects: 0
Study: 25119120

Group type: EXPERIMENTAL
Intervention: Sutures
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Absorbable mesh
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Nonabsorbable mesh
Number of subjects: 126
Study: 24010771

Group type: EXPERIMENTAL
Intervention: Whole-brain irradiation (WBI) with concomitant chloroquine (CLQ) 150 mg for 4 weeks
Number of subjects: 73

Group type: COMPARATOR
Intervention: Whole-brain irradiation (WBI) with placebo for 4 weeks
Number of subjects: 73
Study: 21696614

Group type: EXPERIMENTAL
Intervention: RTA victims
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 150
Study: 18096368

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich fluid (800 mL evening before surgery and 400 mL 2 hours preoperatively)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (overnight fasting)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich fluid
Number of subjects: 70
Study: 16562706

Group type: EXPERIMENTAL
Intervention: Daily health education at DOTS centres
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Directly observed treatment
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Knowledge of TB
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Availability of daily health education
Number of subjects: 234

Group type: COMPARATOR
Intervention: Non-adherent patients
Number of subjects: 234
Study: 12974867

Group type: EXPERIMENTAL
Intervention: Ca(OH)2 and distilled water mixture
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TempCanal
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Calasept
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ca(OH)2 plus point
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (nothing applied)
Number of subjects: 45
Study: 10732825

Group type: EXPERIMENTAL
Intervention: Perilla seed oil-rich supplementation for 4 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Corn oil-rich supplementation for 4 weeks
Number of subjects: 14
Study: 9013264

Group type: EXPERIMENTAL
Intervention: Dobutamine infusion (3 micrograms/kg/min)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Baseline IL6 levels
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: IL6 levels after 24 hours
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: IL6 levels in sicker patients
Number of subjects: 18
Study: 1312340

Group type: EXPERIMENTAL
Intervention: Guar gum (15 g)
Number of subjects: 5
Study: 3877283

Group type: EXPERIMENTAL
Intervention: 2 mg/kg propofol
Number of subjects: 32

Group type: COMPARATOR
Intervention: 0.05 ml/kg Althesin
Number of subjects: 32
Study: 31319882

Group type: EXPERIMENTAL
Intervention: Nocturnal auto‐adjusting continuous positive airway pressure (APAP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nocturnal oxygen therapy (NOT)
Number of subjects: 21
Study: 30407969

Group type: EXPERIMENTAL
Intervention: Auditory stimulation by a male nurse, recorded on MP3, administered twice a day for 10 days, repeated 3 to 4 times.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no auditory stimulation).
Number of subjects: 60
Study: 27391818

Group type: EXPERIMENTAL
Intervention: Structured multi‐component intervention (algorithm‐driven intervention using fixed‐dose combination antihypertensive treatment, subsidized FDC antihypertensive medication, motivational conversation, telephone follow‐ups)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Structured multi‐component intervention
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Structured multi‐component intervention and Usual care (control group)
Number of subjects: 100
Study: 25444830

Group type: EXPERIMENTAL
Intervention: Vaccine alone
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Vaccine plus 10 μg dmLT
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 22406656

Group type: EXPERIMENTAL
Intervention: Tacrolimus QD
Number of subjects: 34

Group type: COMPARATOR
Intervention: Tacrolimus BID
Number of subjects: 34
Study: 19786958

Group type: EXPERIMENTAL
Intervention: Orbscan‐II
Number of subjects: 118

Group type: COMPARATOR
Intervention: Topcon SP‐2000P
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Comparison of devices
Number of subjects: 118
Study: 17637782

Group type: EXPERIMENTAL
Intervention: Uracil‐Ftorafur (UFT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronomodulated delivery schedules for floxuridine and FU infusions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronopharmacology of FU prodrugs
Number of subjects: 0
Study: 15699445

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN)
Number of subjects: 16
Study: 12523588

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 10598761

Group type: EXPERIMENTAL
Intervention: 5% lactic acid
Number of subjects: 32

Group type: COMPARATOR
Intervention: Pure water
Number of subjects: 32
Study: 8619532

Group type: EXPERIMENTAL
Intervention: Gamma knife pallidotomy (180 Gy delivered in one sitting to the right posteroventral pallidum)
Number of subjects: 4
Study: 1672578

Group type: COMPARATOR
Intervention: succinylcholine 2.0 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: vecuronium 0.1 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: vecuronium 0.2 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: vecuronium 0.4 mg/kg
Number of subjects: 40
Study: 7037034

Group type: EXPERIMENTAL
Intervention: Slow-release aminophylline (Phyllocontin) 325 mg twice daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Slow-release theophylline (Rona‐slophyllin) 250 mg twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Patients with plasma theophylline levels greater than 10 micrograms/ml
Number of subjects: 20
Study: 31039724

Group type: EXPERIMENTAL
Intervention: Realistic patterns of species loss (community disassembly)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Randomized patterns of species loss
Number of subjects: 147
Study: 28337838

Group type: EXPERIMENTAL
Intervention: mavoglurant 400 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: baclofen 40 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: mavoglurant 50 mg
Number of subjects: 30
Study: 26351530

Group type: EXPERIMENTAL
Intervention: ALAnerv® (2cps/day for 28 days)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: ALAnerv®
Number of subjects: 59
Study: 22764199

Group type: EXPERIMENTAL
Intervention: Waiting longer during the initial PVI procedure (wait group)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Immediate termination of the procedure after initial successful isolation (stop group)
Number of subjects: 107